학술논문
P1.16-26 Safety of SABR (Stereotactic Ablative Body Radiotherapy) for Central Non-Small Cell Lung Cancers (cNSCLC) with 50 Gray in 5 Fractions (50Gy/5f)
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology October 2018 13(10) Supplement:S637-S637
Subject
Language
ISSN
1556-0864